Medpace
MEDP
788 hedge funds and large institutions have $13.4B invested in Medpace in 2025 Q4 according to their latest regulatory filings, with 180 funds opening new positions, 263 increasing their positions, 257 reducing their positions, and 53 closing their positions.
240% more first-time investments, than exits
New positions opened: 180 | Existing positions closed: 53
17% more funds holding
Funds holding: 673 → 788 (+115)
8% more capital invested
Capital invested by funds: $12.3B → $13.4B (+$1.03B)
2% more repeat investments, than reductions
Existing positions increased: 263 | Existing positions reduced: 257
0.94% less ownership
Funds ownership: 85.33% → 84.39% (-0.94%)
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
72% less call options, than puts
Call options by funds: $14.3M | Put options by funds: $51.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$184M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$111M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$104M |
| 4 |
Goldman Sachs
New York
|
+$94.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$46.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$158M |
| 2 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$136M |
| 3 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$86.8M |
| 4 |
FPP
Findlay Park Partners
London,
United Kingdom
|
-$72.6M |
| 5 |
CCP
Clarkston Capital Partners
Rochester,
Michigan
|
-$63.3M |
MEDP Hedge Fund Activity: Q4 2025 in Review
788 of the 8,284 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2025, worth a combined $13.4B — up 8.4% from $12.3B a quarter earlier.
Buyers outnumbered sellers: 180 funds opened new MEDP positions and 53 closed out — a net gain of 127 holders — while 263 added to existing stakes and 257 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $184M. The largest seller was Wasatch Advisors, cutting an estimated $158M.
- 788 institutional investors held Medpace (MEDP) as of Q4 2025, up from 673 in Q3 2025.
- Funds reported $13.4B of Medpace stock for Q4 2025, up 8.4% quarter-over-quarter.
- 180 funds opened new Medpace positions in Q4 2025 and 53 closed out, a net change of +127 holders.
- The largest Medpace buyer in Q4 2025 was AQR Capital Management, an estimated $184M added.
- The largest Medpace seller in Q4 2025 was Wasatch Advisors, an estimated $158M sold.
Based on aggregated 13F filings for Q4 2025.